Hsa-miR-۶۶۲ as a New Prognostic Biomarker in Patients with Breast Cancer; In-silico and Experimental Study
محل انتشار: مجله علوم پیشرفته زیست پزشکی، دوره: 12، شماره: 4
سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 115
فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JABS-12-4_005
تاریخ نمایه سازی: 31 تیر 1402
چکیده مقاله:
Background & Objective: Breast cancer (BC) is a complex genetic disease that has an average annual incidence of one million people and is the second leading cause of death among women in the world. Therefore, a better understanding of tumor biology and the determination of biomarkers for early diagnosis of disease is essential. MicroRNAs and long non-coding RNAs are novel gene regulators that play key roles in tumor initiation and progression. The current study was performed to assess the biomarker potential. This study performed a combination of in-silico and experimental investigations of altered miRNAs in BC to assess the use of miRNAs as novel biomarkers for early detection and prognosis prediction of patients with BC.
Materials & Methods: We searched the miRNA expression patterns of BC from three expression arrays (GSE۵۸۶۰۶, GSE۳۸۸۶۷, and GSE۴۰۵۲۵,) from the Gene Expression Omnibus (GEO) database to recognize differentially expressed miRNAs (DEMs) between BC tissues and normal adjacent samples. Using “Limma" package's Quantile Normalization function and INMEX bioinformatic tool, hub DEMs were identified. MiRNAs targeted genes were found and visualized via the miRWalk and miRTargetLink databases and their Enrichment analysis was performed for identified genes. Due to more validation of DEGs, GSE۷۰۹۵۱, an independent expression array dataset, was analyzed. By merging DEMs and DEGs, miRNA-mRNA network was constructed. After elucidation of hub miRNAs, the capacity of detected miRNAs to differentiate BC from adjacent controls was estimated by Kaplan-Meier analysis. Furthermore, RT-qPCR on ۱۰۰ BC samples and ۱۰۰ adjacent non-tumor tissues was performed to validate the in-silico results.
Results: According to our study, in BC samples, miR-۶۶۲ was differentially downregulated in comparison with normal adjacent tissues.
Conclusion: Altogether, miR-۶۶۲ can be considered as a viable target for BC diagnostics and treatment.
کلیدواژه ها:
نویسندگان
زهرا فروزنده
Department of Molecular Genetics, Ahar Branch, Islamic Azad University, Ahar, Iran
محمدرضا علیوند
Eye Research Center, the Five Senses Health Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
مهدی قیامی راد
Department of Microbiology, Faculty of Basic Sciences, Ahar Branch, Islamic Azad University, Ahar, Iran
محمد ضعیفی زاده
Department of Biology, Faculty of Sciences, Ardabil Branch, Islamic Azad University, Ardabil, Iran
سعید قربیان
Department of Molecular Genetics, Ahar Branch, Islamic Azad University, Ahar, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :